Value stocks offer stability for investors by focusing on companies that seem underpriced compared to their actual worth. This approach involves looking for stocks with strong fundamentals and growth potential. By investing in these stocks, investors can achieve significant returns once the market recognizes their true value.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
One way to identify value stocks is by comparing a company’s price-to-earnings (P/E) ratio with industry averages or its historical P/E ratios. This ratio compares a company’s stock price to its earnings per share. It must be noted that a lower P/E ratio may indicate that the stock is undervalued. Along with this, we have zeroed in on stocks that have received “Strong Buy” ratings from Wall Street analysts.
Here Are This Week’s Stocks
Micron (MU) – Micron provides memory and storage solutions, producing DRAM, NAND, and other semiconductor products. It has a Strong Buy analyst consensus rating and an average price target of $153.85, implying a 30.14% upside potential from the current levels. The company’s P/E of 21.01x reflects a 17.6% discount to the Technology sector’s median of 25.50.
MU stock is up about 2% at the time of writing after an investment group, CLSA, initiated coverage with a Buy rating and $155 price target, implying 30.9% upside. The firm believes that Micron can gain from rising demand for high-bandwidth memory.
CVS Health (CVS) – This healthcare company provides pharmacy services, retail clinics, and insurance through its Aetna subsidiary. Its average price target of $83.44 implies a 16.16% upside potential from the current levels. CVS stock has a Strong Buy consensus rating. Trading at a P/E of 19.87x, the company is valued 24.3% below the Healthcare sector’s median multiple of 26.26.
On August 20, a federal judge ordered CVS Health’s Caremark unit to pay nearly $290 million for overcharging Medicare on prescription drugs. The unit was found guilty of submitting inflated drug cost reports, resulting in a penalty under the False Claims Act.
Walt Disney (DIS) – Walt Disney is a global entertainment conglomerate known for its iconic brands in media, theme parks, and film production. It has a Strong Buy analyst consensus rating and an average price target of $136.80, implying a 16.07% upside potential from the current levels. With a P/E ratio of 18.45x, the stock is priced at a 10.7% discount to the Communication Services sector’s median of 20.65.
Disney recently sued Dish Network (DISH), alleging Sling TV’s new short-term subscription packages breach their licensing agreement. The company wants its channels removed, claiming the offerings were launched without consent.
What Is TipRanks’ Smart Value Newsletter?
TipRanks’ Smart Value Newsletter helps investors identify high-potential value stocks with strong fundamentals and long-term growth potential, based on TipRanks’ data and analysis. The newsletter, published weekly, includes macroeconomic, market-wide, and company-specific analysis to help investors understand the trends that affect value investing.
Stay ahead of the market – subscribe now!